Bell's palsy. Bell's palsy
Conditions
Interventions
Intervention 1: Intervention group: 10 patients with Bell's palsy will undergo 10 sessions of low-level laser treatment. Intervention 2: Intervention group2: 10 patients with Bell's palsy will undergo
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Age between 18 and 70 years old 2. Diagnosis of acute unilateral Bell's palsy within the past 10 days. The diagnosis must be made clinically and by ruling out other causes. 3. House-Brackmann scale score =3 at baseline 4. Receive standard drug treatment (corticosteroids ± antiviral drugs) 5. Ability and willingness to provide written informed consent 6. Possibility to attend follow-up meetings until the end
Exclusion criteria
Exclusion criteria: 1. Facial palsy with a cause other than Bell's palsy, such as: stroke, tumors (such as acoustic neuroma), Lyme disease, Ramsey-Hunt syndrome, trauma or surgical injury 2. Previous history of Bell's palsy or facial nerve palsy on the same side 3. History of laser sensitivity or conditions that contraindications to laser use, such as: Photosensitive epilepsy, Use of photosensitizing medications 4. Open wound or active infection or skin disease in the treatment area 5. Presence of malignancy in the face or neck area 6. Pregnancy or breastfeeding 7. major chronic neurological diseases such as MS 8. Participation in other concurrent intervention studies 9. Starting physiotherapy or electrical stimulation before entering the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Facial Disability Index (FDI) score. Timepoint: Before starting laser therapy (time zero), immediately after the end of treatment with 10 laser sessions, and one month after the end of treatment. Method of measurement: A short, self-report questionnaire consisting of 10 items or questions.;House-Brackmann system score. Timepoint: Before starting laser therapy (time zero), immediately after the end of treatment with 10 laser sessions, and one month after the end of treatment. Method of measurement: Evaluation of facial nerve function by physician's examination.;Sunnybrook Facial Grading System score. Timepoint: Before starting laser therapy (time zero), immediately after the end of treatment with 10 laser sessions, and one month after the end of treatment. Method of measurement: Evaluation of facial nerve function by physician's examination.;Electrodiagnostic test findings. Timepoint: Before starting laser therapy (time zero), immediately after the end of treatment with 10 laser sessions, and one month after the end of treatment. Method of measurement: Findings from muscle and nerve conduction studies. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammadreza Saadati
Shahid Beheshti University of Medical Sciences
Outcome results
None listed